Browsing: International Medical Approval

–  TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age of Six.…

SHANGHAI, Oct. 27, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest,” or the “Company”), a biopharmaceutical company focused on the development,…

MISSISSAUGA, ON and KIRKLAND, QC, Oct. 19, 2023 /PRNewswire/ — Sumitomo Pharma Canada, Inc. and Pfizer Canada today announced that Health…

CE mark approval follows the US FDA approval from December 2022. Treatment can enable qualifying patients to have their second…

HONG KONG, July 28, 2023 /PRNewswire/ — In the face of ever-changing circumstances, technological innovation remains the eternal driving force…

Company and Yale University Hospital seeking participants with GA for Phase 1 trials of medicine FDA-approved for other ailments NEW…

Mitra® and hemaPEN® receive regulatory certification as medical devices for remote blood sample collection in healthcare, clinical trials and home…